TABLE 1.
Dataset name | Study | Data type | Brain region | Total individuals | Controls | AD cases | Other |
DLPFC | ROS/MAP | Bulk RNAseq | Dorsolateral Prefrontal Cortex | 1092 | 138 | 285 | 669 |
FP | MSBB | Bulk RNAseq | Frontal Pole | 134 | 44 | 90 | 0 |
IFG | MSBB | Bulk RNAseq | Inferior Frontal Gyrus | 112 | 34 | 78 | 0 |
PHG | MSBB | Bulk RNAseq | Parahippocampal Gyrus | 104 | 38 | 66 | 0 |
STG | MSBB | Bulk RNAseq | Superior Temporal Gyrus | 117 | 35 | 82 | 0 |
TCX | Mayo Clinic | Bulk RNAseq | Temporal Cortex | 147 | 67 | 80 | 0 |
Mathys | ROS/MAP | snRNAseq | Dorsolateral Prefrontal Cortex | 47 | 9 | 16 | 22 |
Zhou | ROS/MAP | snRNAseq | Dorsolateral Prefrontal Cortex | 32 | 8 | 8 | 16 |
Cain | ROS/MAP | snRNAseq | Dorsolateral Prefrontal Cortex | 24 | 5 | 5 | 14 |
AIBS snRNAseq | Allen Institute | snRNAseq | Cingulate Gyrus and Medial Temporal Gyrus | 3 | 3 | 0 | 0 |
Counts of individuals include only samples passing Quality Control.Column of individuals denoted as “Other” indicate individuals from the ROS/MAP cohort not meeting either of the defined control or AD case criteria used in mega-analyses of all cohorts.Note that some individuals from the Mount Sinai Brain Bank, MSBB, were sampled multiple times from different brain regions; therefore, not all samples are independent.